Boai Historical Income Statement

300109 Stock

17.75 2.96 20.01%

Historical analysis of Boai NKY income statement accounts such as Interest Expense of 2 M, Selling General Administrative of 21.8 M or Selling And Marketing Expenses of 33.8 M can show how well Boai NKY Pharmaceuticals performed in making a profits. Evaluating Boai NKY income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Boai NKY's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Boai NKY Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Boai NKY Pharmaceuticals is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boai NKY Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Boai Income Statement Analysis

Boai NKY Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Boai NKY shareholders. The income statement also shows Boai investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Boai NKY Income Statement Chart

At present, Boai NKY's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 946.2 M, whereas Depreciation And Amortization is forecasted to decline to about 44.7 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Income Before Tax Minority Interest

Total Revenue

Total revenue comprises all receipts Boai NKY Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Boai NKY Pharmaceuticals minus its cost of goods sold. It is profit before Boai NKY operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Boai NKY income statement and is an important metric when analyzing Boai NKY Pharmaceuticals profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Boai NKY Pharmaceuticals whose combined shares represent less than 50% of the total outstanding shares issued by Boai NKY have a minority interest in Boai NKY.

Most accounts from Boai NKY's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Boai NKY Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boai NKY Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Interest Expense	37.7M	2.6M	2.1M	2.0M
Depreciation And Amortization	181.0M	151.3M	74.2M	44.7M

Interest Expense Depreciation And Amortization

Boai NKY income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Tax Provision	Net Interest Income	Interest Income	Net Income From Continuing Ops	Minority Interest	Reconciled Depreciation
Depreciation And Amortization		0.33	0.74	0.78	0.71	0.6	0.81	0.62	0.63	0.73	0.82	0.35	0.61	0.0	0.57	0.85	0.81	0.92	0.22	0.85	0.5	0.88	0.81
Interest Expense	0.33		0.82	0.67	0.29	0.2	0.43	0.1	0.12	0.16	0.39	0.02	-0.02	-0.79	-0.05	0.16	0.65	0.17	-0.82	0.1	-0.15	0.1	0.24
Selling General Administrative	0.74	0.82		0.94	0.7	0.61	0.82	0.56	0.57	0.63	0.79	0.4	0.47	-0.59	0.43	0.66	0.93	0.67	-0.42	0.49	0.33	0.55	0.72
Selling And Marketing Expenses	0.78	0.67	0.94		0.82	0.74	0.89	0.66	0.68	0.73	0.88	0.51	0.59	-0.47	0.56	0.73	0.99	0.75	-0.3	0.43	0.45	0.61	0.79
Total Revenue	0.71	0.29	0.7	0.82		0.99	0.98	0.96	0.96	0.97	0.98	0.86	0.92	-0.18	0.9	0.93	0.83	0.84	0.07	0.47	0.85	0.71	0.91
Gross Profit	0.6	0.2	0.61	0.74	0.99		0.93	0.97	0.98	0.96	0.93	0.92	0.95	-0.13	0.94	0.89	0.76	0.77	0.1	0.37	0.89	0.64	0.87
Other Operating Expenses	0.81	0.43	0.82	0.89	0.98	0.93		0.89	0.9	0.94	1.0	0.75	0.85	-0.25	0.82	0.93	0.91	0.87	-0.01	0.57	0.75	0.74	0.92
Operating Income	0.62	0.1	0.56	0.66	0.96	0.97	0.89		1.0	0.99	0.9	0.94	0.99	0.0	0.98	0.93	0.68	0.82	0.25	0.5	0.96	0.72	0.9
Ebit	0.63	0.12	0.57	0.68	0.96	0.98	0.9	1.0		0.99	0.9	0.94	0.99	0.01	0.98	0.93	0.7	0.82	0.23	0.49	0.95	0.73	0.9
Ebitda	0.73	0.16	0.63	0.73	0.97	0.96	0.94	0.99	0.99		0.94	0.88	0.98	0.01	0.96	0.97	0.76	0.88	0.25	0.59	0.93	0.8	0.93
Cost Of Revenue	0.82	0.39	0.79	0.88	0.98	0.93	1.0	0.9	0.9	0.94		0.75	0.86	-0.22	0.83	0.94	0.89	0.88	0.03	0.57	0.76	0.76	0.92
Total Operating Expenses	0.35	0.02	0.4	0.51	0.86	0.92	0.75	0.94	0.94	0.88	0.75		0.93	0.0	0.94	0.76	0.53	0.62	0.19	0.27	0.93	0.48	0.78
Income Before Tax	0.61	-0.02	0.47	0.59	0.92	0.95	0.85	0.99	0.99	0.98	0.86	0.93		0.14	1.0	0.92	0.61	0.82	0.37	0.53	0.98	0.75	0.88
Total Other Income Expense Net	0.0	-0.79	-0.59	-0.47	-0.18	-0.13	-0.25	0.0	0.01	0.01	-0.22	0.0	0.14		0.17	0.04	-0.41	0.06	0.84	0.25	0.24	0.22	-0.06
Net Income	0.57	-0.05	0.43	0.56	0.9	0.94	0.82	0.98	0.98	0.96	0.83	0.94	1.0	0.17		0.9	0.58	0.79	0.38	0.49	0.99	0.72	0.85
Income Tax Expense	0.85	0.16	0.66	0.73	0.93	0.89	0.93	0.93	0.93	0.97	0.94	0.76	0.92	0.04	0.9		0.77	0.96	0.33	0.75	0.86	0.87	0.96
Research Development	0.81	0.65	0.93	0.99	0.83	0.76	0.91	0.68	0.7	0.76	0.89	0.53	0.61	-0.41	0.58	0.77		0.77	-0.26	0.48	0.48	0.62	0.82
Tax Provision	0.92	0.17	0.67	0.75	0.84	0.77	0.87	0.82	0.82	0.88	0.88	0.62	0.82	0.06	0.79	0.96	0.77		0.35	0.82	0.76	0.92	0.96
Net Interest Income	0.22	-0.82	-0.42	-0.3	0.07	0.1	-0.01	0.25	0.23	0.25	0.03	0.19	0.37	0.84	0.38	0.33	-0.26	0.35		0.47	0.45	0.4	0.22
Interest Income	0.85	0.1	0.49	0.43	0.47	0.37	0.57	0.5	0.49	0.59	0.57	0.27	0.53	0.25	0.49	0.75	0.48	0.82	0.47		0.48	0.82	0.71
Net Income From Continuing Ops	0.5	-0.15	0.33	0.45	0.85	0.89	0.75	0.96	0.95	0.93	0.76	0.93	0.98	0.24	0.99	0.86	0.48	0.76	0.45	0.48		0.7	0.82
Minority Interest	0.88	0.1	0.55	0.61	0.71	0.64	0.74	0.72	0.73	0.8	0.76	0.48	0.75	0.22	0.72	0.87	0.62	0.92	0.4	0.82	0.7		0.8
Reconciled Depreciation	0.81	0.24	0.72	0.79	0.91	0.87	0.92	0.9	0.9	0.93	0.92	0.78	0.88	-0.06	0.85	0.96	0.82	0.96	0.22	0.71	0.82	0.8

Click cells to compare fundamentals

Boai NKY Account Relationship Matchups

Boai NKY income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	43.0M	52.5M	181.0M	151.3M	74.2M	44.7M
Interest Expense	49.0M	51.6M	37.7M	2.6M	2.1M	2.0M
Selling General Administrative	46.9M	52.3M	60.1M	31.0M	33.5M	21.8M
Selling And Marketing Expenses	60.5M	69.8M	71.9M	65.2M	67.5M	33.8M
Total Revenue	924.4M	978.5M	1.2B	1.5B	1.6B	1.7B
Gross Profit	440.4M	429.9M	492.9M	690.6M	901.1M	946.2M
Other Operating Expenses	692.6M	819.4M	1.1B	1.1B	977.2M	1.0B
Operating Income	237.2M	161.6M	400.2M	388.7M	613.0M	643.6M
Ebit	237.2M	161.6M	400.2M	388.7M	597.2M	627.1M
Ebitda	280.2M	214.1M	581.2M	540.0M	671.4M	705.0M
Cost Of Revenue	484.0M	548.6M	727.4M	795.1M	689.0M	723.5M
Total Operating Expenses	208.5M	270.8M	333.3M	255.0M	977.2M	1.0B
Income Before Tax	158.8M	67.0M	402.9M	388.5M	614.1M	644.8M
Total Other Income Expense Net	(78.4M)	(94.6M)	2.6M	(203.4K)	1.1M	1.2M
Net Income Applicable To Common Shares	122.8M	44.6M	293.1M	291.5M	335.2M	351.9M
Net Income	122.8M	32.6M	293.1M	291.5M	493.0M	517.7M
Income Tax Expense	33.0M	34.4M	122.0M	107.0M	99.6M	104.6M
Research Development	49.3M	70.3M	75.5M	65.7M	63.7M	37.8M
Tax Provision	33.0M	34.4M	122.0M	107.0M	99.6M	60.6M
Net Interest Income	(47.3M)	(47.1M)	7.9M	19.4M	10.6M	11.1M
Interest Income	2.6M	5.6M	48.4M	23.5M	13.6M	14.5M
Net Income From Continuing Ops	125.7M	32.6M	280.9M	281.4M	485.8M	510.1M
Minority Interest	4.7M	(2.5M)	12.2M	10.0M	7.2M	4.8M
Reconciled Depreciation	43.0M	52.5M	71.9M	61.9M	74.2M	59.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Boai Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boai Historical Income Statement

About Boai Income Statement Analysis

Boai NKY Income Statement Chart

Total Revenue

Gross Profit

Income Before Tax

Minority Interest

Boai NKY income statement Correlations

Boai NKY Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boai NKY income statement Accounts

Also Currently Popular

Other Information on Investing in Boai Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Net Income	+ 1.0	Income Before Tax
Research Development	+ 0.99	Selling And Marketing Expenses
Gross Profit	+ 0.99	Total Revenue
Ebitda	+ 0.99	Operating Income

Net Interest Income	- 0.82	Interest Expense
Total Other Income Expense Net	- 0.79	Interest Expense
Total Other Income Expense Net	- 0.59	Selling General Administrative
Total Other Income Expense Net	- 0.47	Selling And Marketing Expenses
Net Interest Income	- 0.42	Selling General Administrative
Research Development	- 0.41	Total Other Income Expense Net